The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.93

Today's change+0.09 +2.34%
Updated July 22 3:59 PM EDT. Delayed by at least 15 minutes.
 

BioAmber Inc

NYSE: BIOA
Last

(U.S.) $3.93

Today's change+0.09 +2.34%
Updated July 22 3:59 PM EDT. Delayed by at least 15 minutes.

BioAmber Inc up sharply

BioAmber Inc closed up sharply Friday, rallying (U.S.)$0.09 or 2.34% to (U.S.)$3.93. Over the last five days, shares have gained 9.47%, but are down 36.41% for the last year to date. Shares have underperformed the S&P 500 by 51.91% during the last year.

Key company metrics

  • Open(U.S.) $3.86
  • Previous close(U.S.) $3.84
  • High(U.S.) $3.95
  • Low(U.S.) $3.78
  • Bid / Ask-- / --
  • YTD % change-36.41%
  • Volume25,507
  • Average volume (10-day)43,680
  • Average volume (1-month)34,738
  • Average volume (3-month)37,821
  • 52-week range(U.S.) $2.86 to (U.S.) $8.92
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.47
Updated July 22 3:59 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,366.69%

BioAmber Inc has a net profit margin of -1,366.69%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.24%Sector:Basic MaterialsIndustry:Chemicals - Specialty

Latest Company News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1100
Total other revenue--------
Total revenue1100
Gross profit-2000
Total cost of revenue3101
Total operating expense10101011
Selling / general / administrative4434
Research & development2565
Depreciation / amortization1100
Interest expense (income), net operating--------
Unusual expense (income)--001
Other operating expenses, total--------
Operating income-9-9-10-11
Interest income (expense), net non-operating-1-2-1-1
Gain (loss) on sale of assets--------
Other--------
Income before tax-13-9-8-15
Income after tax-13-9-8-15
Income tax, total0000
Net income-11-8-7-14
Total adjustments to net income--------
Net income before extra. items-11-8-7-14
Minority interest2111
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-11-8-7-14
Inc. avail. to common incl. extra. items-11-8-7-14
Diluted net income-11-8-7-14
Dilution adjustment--------
Diluted weighted average shares28262624
Diluted EPS excluding extraordinary itemsvalue per share-0.39-0.30-0.27-0.58
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.39-0.30-0.27-0.55